Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Procedural topic
No spam. Unsubscribe anytime.
Votes and actions at a glance: Population Health Subcommittee, March 3, 2026
Summary
Key roll calls: HB2075 (ibogaine clinical‑trial framework) advanced 8–2; HB2290 (IVF‑clinic certification) advanced 6–3; HB1943 (ER treatment for pregnant patients) rolled one week; HB0179 (life‑of‑mother exceptions) failed 8–2.
At the March 3 Population Health Subcommittee meeting the following formal outcomes were recorded:
- HB2075 (Helping Open Pathways to Effective Treatment Act): advanced to full Health committee. Clerk announced 8 ayes, 2 nays. (See sponsor discussion and testimony.)
- HB2290 (Fertility clinic certification): advanced to full Health committee. Clerk announced 6 ayes, 3 nays after adoption of amendments and sponsor explanation.
- HB1943 (Emergency‑room treatment for pregnant patients): committee adopted and then clarified overlapping amendments; the sponsor elected to roll the bill for one week for language revision to avoid conflicts with federal EMTALA.
- HB0179 (Narrow exceptions for life‑of‑the‑mother situations): motion failed; clerk read final vote as 8 to 2 against moving the measure forward.
These tallies were announced by the clerk on the record during the hearing.
